secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardlytics, Inc. (CDLX)
CIK:        0001666071
Form:       8-K
Filed at:   2026-06-03T20:26:51+00:00
Accession:  0001628280-26-040351
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardlytics receives Nasdaq deficiency notice; implements 1-for-10 reverse stock split
--------------------------------------------------------------------------------

- Nasdaq notified CDLX that bid price closed below $1 for 30 consecutive days; 180-day cure period ends Nov 30, 2026.
- Company filed Charter Amendment for 1-for-10 reverse stock split effective June 5, 2026; trading on split-adjusted basis June 8.
- Authorized shares reduced from 100M to 10M; outstanding shares to drop from ~58M to ~5.8M, subject to fractional cash-out.
- Proportionate adjustments made to 4.25% Convertible Notes due 2029, stock options, and RSUs.
- If compliance not met by Nov 30, CDLX may seek second 180-day period or face delisting; reverse split aims to cure deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1666071/000162828026040351/0001628280-26-040351-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1666071/000162828026040351/cdlx-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-040351

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer